Advertisement

---

TOLERION INC.

Newly Published Phase 2 Data Show Tolerion's Reverse Vaccine May Have Disease-Modifying Potential in Type 1 Diabetes

[2013-06-26] - --Novel Approach May Have Potential to Revolutionize Treatment of Certain Autoimmune Diseases By Selectively Neutralizing Destructive Self-Antigens While Leaving Rest of Immune System Unaffected--
--In Phase 2 trial, TOL-3021 Increased Pancreatic Beta Cell Function and Reduced Disease-Specific T-Cell Activity in Patients with Type 1 Diabetes--


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers